While much, if not most, of the discussion on Hepatitis C community pertains to interferon and the various topics surrounding it, I am concerned about so much that is not being talked about, that is generic Harvoni.
Only if they knew about generic Harvoni or Gilead had released its $24,000 Asegua Generic Hepatitis C Treatment.
Harvoni is a prescription medication used to treat Hepatitis C, a liver disease caused by the Hepatitis C virus. Developed by Gilead Sciences, Harvoni is considered a breakthrough drug for Hepatitis C patients, as it has been shown to cure the disease in a high percentage of patients, even those with advanced liver damage.
However, the cost of Harvoni has been a topic of much debate, particularly in the United States, where the drug is significantly more expensive than in other countries, including India.
According to a report by the National Institutes of Health (NIH), Harvoni was first approved by the US Food and Drug Administration (FDA) in October 2014, with a wholesale acquisition cost of $94,500 for a 12-week treatment course.
However, this cost was significantly higher than the cost of other treatments for Hepatitis C, leading to criticism and calls for lower pricing. In response, Gilead Sciences offered discounts to some government programs and negotiated lower prices with private insurers, but the cost of Harvoni remained high for many patients.
In contrast, the cost of Harvoni in India is significantly lower. According to an article in Forbes, Gilead Sciences licensed Harvoni to several Indian generic drug manufacturers, allowing them to produce and sell the drug in India and other low- and middle-income countries at a much lower cost.
In India, a 12-week treatment course of Harvoni costs around $1,000, or less than 1% of the cost in the United States.
The difference in pricing has been a source of controversy, particularly as many Americans have turned to importing Harvoni from countries like India to save on costs.
Despite the high cost of Harvoni in the United States, the drug has been widely prescribed and has been shown to be highly effective in treating Hepatitis C.
According to the NIH report, Harvoni has a cure rate of over 90% in most patients, with few side effects. The drug is typically prescribed for patients with advanced liver damage or who have not responded to other treatments.
In conclusion, Harvoni is a breakthrough medication for the treatment of Hepatitis C, but its high cost in the United States has been a source of controversy.
While the drug is significantly less expensive in countries like India, importing medications from foreign countries is not recommended by the FDA. Patients in the United States should work with their healthcare providers and insurance companies to explore all available options for obtaining affordable treatment.
Cost of Harvoni is Very Affordable. Order Now.
Thousands have been cured with our Harvoni.
It only takes 84 days to clear the hepatitis C virus.
Your liver will feel a thousand times better.
Your body will thank you for it.